Information Library

Results for: Enrollment & retention - Faster product development - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT

    Press Release — May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program

  • FDA Requirements for Clinical Studies in Pediatric Patients

    White Paper — April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Propelling Pediatric Research

    Case Study — April 1, 2010
    Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

  • Boosting Pediatric Enrollment

    Case Study — April 1, 2010
    Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks.

  • Anticipating the Challenge

    Case Study — March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    Case Study — March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    Brochure — July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences